Table 3 Improvement in hearing according to Siegel's criteria at 2 weeks and 2 months after treatment in the PS-matched cohort.
From: Treatment outcomes for idiopathic sudden sensorineural hearing loss in dialysis patients
1:5 propensity-score matched patients | ||||||||
|---|---|---|---|---|---|---|---|---|
Total (n = 282) | Dialysis group (n = 47) | Non-dialysis group (n = 235) | Crude model | Adjusted model | ||||
OR (95% CI) | P-value | OR (95% CI) | P-value | |||||
2-week follow up | ||||||||
CR (%) | 55 (19.5) | 4 (8.5) | 51 (21.7) | 0.34 (0.10–0.88) | 0.046 | 0.16 (0.03–0.64) | 0.018 | |
PR (%) | 36 (12.8) | 5 (10.6) | 31 (13.2) | 0.78 (0.26–1.97) | 0.633 | 0.88 (0.27–2.40) | 0.810 | |
SR (%) | 44 (15.6) | 9 (19.1) | 35 (14.9) | 1.35 (0.57–2.94) | 0.464 | 1.28 (0.49–3.07) | 0.598 | |
No improvement (%) | 147 (52.1) | 29 (61.7) | 118 (50.2) | 1.60 (0.85–3.08) | 0.152 | 2.08 (0.99–4.55) | 0.059 | |
CR or PR (%) | 91 (32.3) | 9 (19.1) | 82 (34.9) | 0.44 (0.19–0.92) | 0.039 | 0.34 (0.12–0.86) | 0.03 | |
CR, PR or SR (%) | 135 (47.9) | 18 (38.3) | 117 (49.8) | 0.63 (0.32–1.18) | 0.152 | 0.48 (0.22–1.01) | 0.059 | |
2-month follow up | ||||||||
CR (%) | 66 (23.4) | 3 (6.4) | 63 (26.8) | 0.19 (0.04–0.53) | 0.006 | 0.15 (0.03–0.57) | 0.012 | |
PR (%) | 44 (15.6) | 8 (17.0) | 36 (15.3) | 1.13 (0.46–2.52) | 0.769 | 1.07 (0.41–2.58) | 0.881 | |
SR (%) | 54 (19.1) | 15 (31.9) | 39 (16.6) | 2.36 (1.14–4.71) | 0.017 | 2.15 (0.94–4.80) | 0.063 | |
No improvement (%) | 118 (41.8) | 21 (44.7) | 97 (41.3) | 1.15 (0.61–2.16) | 0.666 | 1.41 (0.69–2.88) | 0.344 | |
CR or PR (%) | 110 (39.0) | 11 (23.4) | 99 (42.1) | 0.42 (0.20–0.84) | 0.019 | 0.36 (0.14–0.85) | 0.025 | |
CR, PR, or SR (%) | 164 (58.2) | 26 (55.3) | 138 (58.7) | 0.87 (0.46–1.65) | 0.666 | 0.71 (0.35–1.45) | 0.344 | |
